4.70
price down icon5.05%   -0.25
after-market 시간 외 거래: 4.69 -0.010 -0.21%
loading
전일 마감가:
$4.95
열려 있는:
$4.99
하루 거래량:
774.11K
Relative Volume:
0.48
시가총액:
$328.11M
수익:
-
순이익/손실:
$-297.11M
주가수익비율:
-0.9056
EPS:
-5.19
순현금흐름:
$-216.95M
1주 성능:
+15.20%
1개월 성능:
+70.29%
6개월 성능:
-47.49%
1년 성능:
-54.63%
1일 변동 폭
Value
$4.615
$4.99
1주일 범위
Value
$4.05
$4.99
52주 변동 폭
Value
$2.21
$19.71

Phathom Pharmaceuticals Inc Stock (PHAT) Company Profile

Name
명칭
Phathom Pharmaceuticals Inc
Name
전화
(877) 742-8466
Name
주소
100 CAMPUS DRIVE,, FLORHAM PARK, NJ
Name
직원
427
Name
트위터
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
PHAT's Discussions on Twitter

PHAT을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
PHAT
Phathom Pharmaceuticals Inc
4.70 284.84M 0 -297.11M -216.95M -5.19
Biotechnology icon
ONC
Beone Medicines Ltd Adr
258.27 26.01B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
445.85 114.30B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.3499 41.83M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
83.98 6.29B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
484.93 63.90B 14.09B 4.50B 2.96B 39.28

Phathom Pharmaceuticals Inc Stock (PHAT) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-02-14 개시 Cantor Fitzgerald Overweight
2024-05-03 개시 Stifel Buy
2024-01-05 재확인 Needham Buy
2023-08-09 개시 H.C. Wainwright Buy
2023-05-11 업그레이드 Evercore ISI In-line → Outperform
2023-03-13 개시 Craig Hallum Buy
2022-10-21 개시 Jefferies Buy
2022-05-06 다운그레이드 Evercore ISI Outperform → In-line
2021-05-12 업그레이드 Goldman Sell → Neutral
2021-02-17 개시 BMO Capital Markets Outperform
2021-02-02 개시 Guggenheim Buy
2020-06-26 다운그레이드 Goldman Neutral → Sell
2019-11-20 개시 Evercore ISI Outperform
2019-11-19 개시 Goldman Neutral
2019-11-19 개시 Jefferies Buy
2019-11-19 개시 Needham Buy
모두보기

Phathom Pharmaceuticals Inc 주식(PHAT)의 최신 뉴스

pulisher
Jun 03, 2025

ProShare Advisors LLC Has $116,000 Stock Position in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Investors Still Aren't Entirely Convinced By Phathom Pharmaceuticals, Inc.'s (NASDAQ:PHAT) Revenues Despite 54% Price Jump - simplywall.st

Jun 02, 2025
pulisher
Jun 02, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Raises Stake in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) - Defense World

Jun 02, 2025
pulisher
Jun 02, 2025

Deutsche Bank AG Increases Stock Holdings in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) - Defense World

Jun 02, 2025
pulisher
May 27, 2025

Brokerages Set Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) PT at $17.60 - Defense World

May 27, 2025
pulisher
May 27, 2025

BNP Paribas Financial Markets Purchases Shares of 39,532 Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) - Defense World

May 27, 2025
pulisher
May 24, 2025

Northern Trust Corp Has $3.23 Million Position in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) - Defense World

May 24, 2025
pulisher
May 20, 2025

Even after rising 39% this past week, Phathom Pharmaceuticals (NASDAQ:PHAT) shareholders are still down 89% over the past five years - simplywall.st

May 20, 2025
pulisher
May 15, 2025

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewswire

May 15, 2025
pulisher
May 15, 2025

GI Disease Leader Phathom to Present at 3 Elite Healthcare Conferences: Goldman Sachs, Jefferies, H.C. Wainwright - Stock Titan

May 15, 2025
pulisher
May 14, 2025

(PHAT) Proactive Strategies - news.stocktradersdaily.com

May 14, 2025
pulisher
May 12, 2025

Phathom pharmaceuticals outlines VOQUEZNA expansion targets and cost-saving measures for profitability by 2026 - MSN

May 12, 2025
pulisher
May 10, 2025

After Plunging -45.82% in 4 Weeks, Here's Why the Trend Might Reverse for Phathom Pharmaceuticals (PHAT) - MSN

May 10, 2025
pulisher
May 10, 2025

Phathom Pharmaceuticals Sees Unusually High Options Volume (NASDAQ:PHAT) - Defense World

May 10, 2025
pulisher
May 09, 2025

Phathom Pharmaceuticals surges 50% following large insider purchase - MSN

May 09, 2025
pulisher
May 09, 2025

Phathom Pharmaceuticals (PHAT) Shares Surge After Board Member's Large Purchase - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Wells Fargo & Company MN Raises Stock Position in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) - Defense World

May 09, 2025
pulisher
May 08, 2025

Insider Buying: Asit Parikh Acquires Additional Shares of Phathom Pharmaceuticals Inc (PHAT) - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Shares Acquired by Barclays PLC - Defense World

May 08, 2025
pulisher
May 05, 2025

Finance Watch: Unity Lays Off All Employees As It Evaluates Alternatives - insights.citeline.com

May 05, 2025
pulisher
May 05, 2025

HC Wainwright Cuts Phathom Pharmaceuticals (NASDAQ:PHAT) Price Target to $20.00 - Defense World

May 05, 2025
pulisher
May 04, 2025

Retail Interest in Phathom Soars As Firm Pledges Profit Path, Cuts Costs After Q1 Miss - MSN

May 04, 2025
pulisher
May 04, 2025

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Just Reported, And Analysts Assigned A US$18.63 Price Target - Yahoo Finance

May 04, 2025
pulisher
May 04, 2025

The Goldman Sachs Group Issues Pessimistic Forecast for Phathom Pharmaceuticals (NASDAQ:PHAT) Stock Price - Defense World

May 04, 2025
pulisher
May 03, 2025

Phathom Pharmaceuticals First Quarter 2025 Earnings: Misses Expectations - Yahoo

May 03, 2025
pulisher
May 02, 2025

H.C. Wainwright cuts Phathom Pharma stock target to $20, keeps Buy rating - Investing.com Canada

May 02, 2025
pulisher
May 02, 2025

Phathom Pharmaceuticals (PHAT) Price Target Lowered by Goldman S - GuruFocus

May 02, 2025
pulisher
May 02, 2025

Phathom Pharmaceuticals (PHAT) Target Price Lowered by Guggenhei - GuruFocus

May 02, 2025
pulisher
May 02, 2025

Phathom Pharmaceuticals (PHAT) Maintains Buy Rating as Price Tar - GuruFocus

May 02, 2025
pulisher
May 02, 2025

Phathom Pharmaceuticals (PHAT) Maintains Buy Rating as Price Target Drops | PHAT Stock News - GuruFocus

May 02, 2025
pulisher
May 02, 2025

Phathom Pharmaceuticals (PHAT) Price Target Reduced by Guggenhei - GuruFocus

May 02, 2025
pulisher
May 02, 2025

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Q1 2025 Earnings Call Transcript - Insider Monkey

May 02, 2025
pulisher
May 02, 2025

Phathom Pharmaceuticals (PHAT) Price Target Reduced by Guggenheim | PHAT Stock News - GuruFocus

May 02, 2025
pulisher
May 02, 2025

PHAT Faces Price Target Cut Amidst Restructuring Efforts | PHAT Stock News - GuruFocus

May 02, 2025
pulisher
May 02, 2025

Phathom Pharmaceuticals Inc (PHAT) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... - Yahoo Finance

May 02, 2025
pulisher
May 02, 2025

Phathom Pharmaceuticals Inc (PHAT) Q1 2025 Earnings Call Highlig - GuruFocus

May 02, 2025
pulisher
May 02, 2025

Phathom Pharmaceuticals Reports Q1 2025 Financial Results - TipRanks

May 02, 2025
pulisher
May 01, 2025

Phathom Pharmaceuticals Eyes Profitability Amid Growth - TipRanks

May 01, 2025
pulisher
May 01, 2025

Phathom Pharmaceuticals Q1 2025 Earnings Call Transcript - MarketBeat

May 01, 2025
pulisher
May 01, 2025

Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | PHAT Stock News - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

May 01, 2025
pulisher
May 01, 2025

Phathom Pharmaceuticals Grants 186,508 Shares Package to New Sales Chief in Strategic Hire - Stock Titan

May 01, 2025
pulisher
May 01, 2025

Phathom (PHAT) Implements Strategic Shift for Long-Term Growth | - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Phathom Pharmaceuticals Q1 2025 Earnings: EPS Matches Estimates at -$1.18, Revenue Falls Short at $28.5 Million - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Arvinas ends plans for two Phase 3 breast cancer trials; Phathom makes cuts - Endpoints News

May 01, 2025
pulisher
May 01, 2025

Phathom Pharmaceuticals stock hits 52-week low at $3.8 By Investing.com - Investing.com India

May 01, 2025
pulisher
May 01, 2025

Phathom Pharmaceuticals to Report First Quarter 2025 Financial R - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Phathom Pharmaceuticals stock hits 52-week low at $3.8 - Investing.com

May 01, 2025
pulisher
May 01, 2025

Earnings call transcript: Phathom Pharmaceuticals beats Q1 2025 earnings expectations - Investing.com

May 01, 2025
pulisher
May 01, 2025

Phathom Pharmaceuticals, Inc. (PHAT) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 01, 2025
pulisher
May 01, 2025

Phathom Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update - The Manila Times

May 01, 2025

Phathom Pharmaceuticals Inc (PHAT) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$1.16
price up icon 0.00%
$573.50
price down icon 0.54%
$36.08
price up icon 15.90%
$305.31
price up icon 0.51%
$4.75
price up icon 3.70%
$484.93
price down icon 0.60%
자본화:     |  볼륨(24시간):